140 related articles for article (PubMed ID: 22503713)
21. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
[TBL] [Abstract][Full Text] [Related]
22. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
Schröder FH
Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
[TBL] [Abstract][Full Text] [Related]
23. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
24. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
[TBL] [Abstract][Full Text] [Related]
25. Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
Narimoto K; Mizokami A; Izumi K; Mihara S; Sawada K; Sugata T; Shimamura M; Miyazaki K; Nishino A; Namiki M
Int J Urol; 2010 Apr; 17(4):337-45. PubMed ID: 20202011
[TBL] [Abstract][Full Text] [Related]
26. [Keyrole of endocrinology in the victory against prostate cancer].
Labrie F
Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
[TBL] [Abstract][Full Text] [Related]
27. Overview of enzyme inhibitors and anti-androgens in prostatic cancer.
Geller J
J Androl; 1991; 12(6):364-71. PubMed ID: 1769904
[TBL] [Abstract][Full Text] [Related]
28. Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
[TBL] [Abstract][Full Text] [Related]
29. Androgen biosynthetic pathways in the human prostate.
Luu-The V; Bélanger A; Labrie F
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):207-21. PubMed ID: 18471780
[TBL] [Abstract][Full Text] [Related]
30. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
Attardi BJ; Burgenson J; Hild SA; Reel JR
Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
[TBL] [Abstract][Full Text] [Related]
31. RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation.
Rinaldo F; Li J; Wang E; Muders M; Datta K
Oncogene; 2007 Mar; 26(12):1731-8. PubMed ID: 16964283
[TBL] [Abstract][Full Text] [Related]
32. Intracrinology-revisited and prostate cancer.
Penning TM; Detlefsen AJ
J Steroid Biochem Mol Biol; 2020 Feb; 196():105499. PubMed ID: 31614208
[TBL] [Abstract][Full Text] [Related]
33. Circulating steroid hormone variations throughout different stages of prostate cancer.
Snaterse G; Visser JA; Arlt W; Hofland J
Endocr Relat Cancer; 2017 Nov; 24(11):R403-R420. PubMed ID: 28924064
[TBL] [Abstract][Full Text] [Related]
34. The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate.
McNamara KM; Handelsman DJ; Simanainen U
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):107-21. PubMed ID: 22146616
[TBL] [Abstract][Full Text] [Related]
35. Intracrine androgen biosynthesis, metabolism and action revisited.
Schiffer L; Arlt W; Storbeck KH
Mol Cell Endocrinol; 2018 Apr; 465():4-26. PubMed ID: 28865807
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer.
Ferraldeschi R; Sharifi N; Auchus RJ; Attard G
Clin Cancer Res; 2013 Jul; 19(13):3353-9. PubMed ID: 23470964
[TBL] [Abstract][Full Text] [Related]
37. Applying mass spectrometric methods to study androgen biosynthesis and metabolism in prostate cancer.
Knuuttila M; Hämäläinen E; Poutanen M
J Mol Endocrinol; 2019 May; 62(4):R255-R267. PubMed ID: 30917337
[TBL] [Abstract][Full Text] [Related]
38. Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.
Cho E; Montgomery RB; Mostaghel EA
Endocrinology; 2014 Nov; 155(11):4124-32. PubMed ID: 25147980
[TBL] [Abstract][Full Text] [Related]
39. Basics of androgen synthesis and action.
Naamneh Elzenaty R; du Toit T; Flück CE
Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101665. PubMed ID: 35595638
[TBL] [Abstract][Full Text] [Related]
40. Sex steroids in the tumor microenvironment and prostate cancer progression.
Boibessot C; Toren P
Endocr Relat Cancer; 2018 Mar; 25(3):R179-R196. PubMed ID: 29317479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
